{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:29:42Z","timestamp":1790281782944,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00011-024-01943-z","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T06:01:53Z","timestamp":1727503313000},"page":"1945-1960","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Olink proteomics and lipidomics analysis of serum from patients infected with non-tuberculous mycobacteria and Mycobacterium tuberculosis"],"prefix":"10.1007","volume":"73","author":[{"given":"Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"key":"1943_CR1","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1378\/chest.15-0458","volume":"148","author":"PJ McShane","year":"2015","unstructured":"McShane PJ, Glassroth J. Pulmonary Disease due to Nontuberculous Mycobacteria: current state and New insights. Chest. 2015;148:1517\u201327. https:\/\/doi.org\/10.1378\/chest.15-0458.","journal-title":"Chest"},{"key":"1943_CR2","doi-asserted-by":"publisher","first-page":"e0007083","DOI":"10.1371\/journal.pntd.0007083","volume":"13","author":"SL Baldwin","year":"2019","unstructured":"Baldwin SL, Larsen SE, Ordway D, Cassell G, Coler RN. The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases. PLoS Negl Trop Dis. 2019;13:e0007083. https:\/\/doi.org\/10.1371\/journal.pntd.0007083.","journal-title":"PLoS Negl Trop Dis"},{"key":"1943_CR3","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.5588\/ijtld.14.0120","volume":"18","author":"SK Brode","year":"2014","unstructured":"Brode SK, Daley CL, Marras TK. The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review. Int J Tuberc Lung Dis. 2014;18:1370\u20137. https:\/\/doi.org\/10.5588\/ijtld.14.0120.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1943_CR4","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1183\/09031936.06.00149805","volume":"28","author":"SJ Fowler","year":"2006","unstructured":"Fowler SJ, French J, Screaton NJ, Foweraker J, Condliffe A, Haworth CS, Exley AR, Bilton D. Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics. Eur Respir J. 2006;28:1204\u201310. https:\/\/doi.org\/10.1183\/09031936.06.00149805.","journal-title":"Eur Respir J"},{"key":"1943_CR5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jinf.2016.08.020","volume":"73","author":"X Yu","year":"2016","unstructured":"Yu X, Liu P, Liu G, Zhao L, Hu Y, Wei G, Luo J, Huang H. The prevalence of non-tuberculous mycobacterial infections in mainland China: systematic review and meta-analysis. J Infect. 2016;73:558\u201367. https:\/\/doi.org\/10.1016\/j.jinf.2016.08.020.","journal-title":"J Infect"},{"key":"1943_CR6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jinf.2016.03.008","volume":"72","author":"GS Smith","year":"2016","unstructured":"Smith GS, Ghio AJ, Stout JE, Messier KP, Hudgens EE, Murphy MS, Pfaller SL, Maillard JM, Hilborn ED. Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006\u20132010. J Infect. 2016;72:678\u201386. https:\/\/doi.org\/10.1016\/j.jinf.2016.03.008.","journal-title":"J Infect"},{"key":"1943_CR7","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.chest.2021.11.014","volume":"161","author":"RC Hull","year":"2022","unstructured":"Hull RC, Huang JTJ, Barton AK, Keir HR, Ellis H, Cookson WOC, Moffatt MF, Loebinger MR, Chalmers JD. Sputum Proteomics in Nontuberculous Mycobacterial Lung Disease. Chest. 2022;161:1180\u201391. https:\/\/doi.org\/10.1016\/j.chest.2021.11.014.","journal-title":"Chest"},{"key":"1943_CR8","doi-asserted-by":"publisher","unstructured":"Wang L, Zheng X, Ma J, Gu J, Sha W. Comparative proteomic analysis of Exosomes Derived from patients infected with non-tuberculous Mycobacterium and Mycobacterium tuberculosis. Microorganisms. 2023;11. https:\/\/doi.org\/10.3390\/microorganisms11092334.","DOI":"10.3390\/microorganisms11092334"},{"key":"1943_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.mib.2017.09.013","volume":"39","author":"A Banaei-Esfahani","year":"2017","unstructured":"Banaei-Esfahani A, Nicod C, Aebersold R, Collins BC. Systems proteomics approaches to study bacterial pathogens: application to Mycobacterium tuberculosis. Curr Opin Microbiol. 2017;39:64\u201372. https:\/\/doi.org\/10.1016\/j.mib.2017.09.013.","journal-title":"Curr Opin Microbiol"},{"key":"1943_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/14789450.2019.1608185","volume":"16","author":"D Bisht","year":"2019","unstructured":"Bisht D, Sharma D, Sharma D, Singh R, Gupta VK. Recent insights into Mycobacterium tuberculosis through proteomics and implications for the clinic. Expert Rev Proteom. 2019;16:443\u201356. https:\/\/doi.org\/10.1080\/14789450.2019.1608185.","journal-title":"Expert Rev Proteom"},{"key":"1943_CR11","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1126\/science.abq2787","volume":"378","author":"Q Liu","year":"2022","unstructured":"Liu Q, Zhu J, Dulberger CL, Stanley S, Wilson S, Chung ES, Wang X, Culviner P, Liu YJ, Hicks ND, Babunovic GH, Giffen SR, Aldridge BB, Garner EC, Rubin EJ, Chao MC, Fortune SM. Tuberculosis treatment failure associated with evolution of antibiotic resilience. Science. 2022;378:1111\u20138. https:\/\/doi.org\/10.1126\/science.abq2787.","journal-title":"Science"},{"key":"1943_CR12","doi-asserted-by":"publisher","first-page":"e2100170","DOI":"10.1002\/pmic.202100170","volume":"22","author":"DE Haslam","year":"2022","unstructured":"Haslam DE, Li J, Dillon ST, Gu X, Cao Y, Zeleznik OA, Sasamoto N, Zhang X, Eliassen AH, Liang L, Stampfer MJ, Mora S, Chen ZZ, Terry KL, Gerszten RE, Hu FB, Chan AT, Libermann TA, Bhupathiraju SN. Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platforms. Proteomics. 2022;22:e2100170. https:\/\/doi.org\/10.1002\/pmic.202100170.","journal-title":"Proteomics"},{"key":"1943_CR13","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2217\/fmb-2018-0013","volume":"13","author":"NR Rameshwaram","year":"2018","unstructured":"Rameshwaram NR, Singh P, Ghosh S, Mukhopadhyay S. Lipid metabolism and intracellular bacterial virulence: key to next-generation therapeutics. Future Microbiol. 2018;13:1301\u201328. https:\/\/doi.org\/10.2217\/fmb-2018-0013.","journal-title":"Future Microbiol"},{"key":"1943_CR14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","volume":"20","author":"P Chandra","year":"2022","unstructured":"Chandra P, Grigsby SJ, Philips JA. Immune evasion and provocation by Mycobacterium tuberculosis. Nat Rev Microbiol. 2022;20:750\u201366. https:\/\/doi.org\/10.1038\/s41579-022-00763-4.","journal-title":"Nat Rev Microbiol"},{"key":"1943_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mib.2017.11.020","volume":"41","author":"G Gago","year":"2018","unstructured":"Gago G, Diacovich L, Gramajo H. Lipid metabolism and its implication in mycobacteria-host interaction. Curr Opin Microbiol. 2018;41:36\u201342. https:\/\/doi.org\/10.1016\/j.mib.2017.11.020.","journal-title":"Curr Opin Microbiol"},{"key":"1943_CR16","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G, Bjorkesten J, Thorsen SB, Ekman D, Eriksson A, Rennel Dickens E, Ohlsson S, Edfeldt G, Andersson AC, Lindstedt P, Stenvang J, Gullberg M, Fredriksson S. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE. 2014;9:e95192. https:\/\/doi.org\/10.1371\/journal.pone.0095192.","journal-title":"PLoS ONE"},{"key":"1943_CR17","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1021\/ac051437y","volume":"78","author":"CA Smith","year":"2006","unstructured":"Smith CA, Want EJ, O\u2019Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006;78:779\u201387. https:\/\/doi.org\/10.1021\/ac051437y.","journal-title":"Anal Chem"},{"key":"1943_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, McSkane M, Baba H, Lenz HJ. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treat Rev. 2018;63:40\u20137. https:\/\/doi.org\/10.1016\/j.ctrv.2017.11.007.","journal-title":"Cancer Treat Rev"},{"key":"1943_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5588\/ijtld.14.0525","volume":"19","author":"K Lee","year":"2015","unstructured":"Lee K, Chung W, Jung Y, Kim Y, Park J, Sheen S, Park K. CXCR3 ligands as clinical markers for pulmonary tuberculosis. Int J Tuberc Lung Dis. 2015;19:191\u20139. https:\/\/doi.org\/10.5588\/ijtld.14.0525.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1943_CR20","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.5588\/ijtld.15.0325","volume":"19","author":"W Chung","year":"2015","unstructured":"Chung W, Lee K, Jung Y, Kim Y, Park J, Sheen S, Lee J, Kang D, Park K. Serum CXCR3 ligands as biomarkers for the diagnosis and treatment monitoring of tuberculosis. Int J Tuberc Lung Dis. 2015;19:1476\u201384. https:\/\/doi.org\/10.5588\/ijtld.15.0325.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1943_CR21","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.5588\/ijtld.17.0232","volume":"21","author":"W Chung","year":"2017","unstructured":"Chung W, Jung Y, Lee K, Park J, Sheen S, Park K. CXCR3 ligands in pleural fluid as markers for the diagnosis of tuberculous pleural effusion. Int J Tuberc Lung Dis. 2017;21:1300\u20136. https:\/\/doi.org\/10.5588\/ijtld.17.0232.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1943_CR22","doi-asserted-by":"publisher","first-page":"18217","DOI":"10.1038\/s41598-019-54803-w","volume":"9","author":"NP Kumar","year":"2019","unstructured":"Kumar NP, Moideen K, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Natarajan M, Kornfeld H, Babu S. Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis. Sci Rep. 2019;9:18217. https:\/\/doi.org\/10.1038\/s41598-019-54803-w.","journal-title":"Sci Rep"},{"key":"1943_CR23","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/imcb.12644","volume":"101","author":"TJ Lupancu","year":"2023","unstructured":"Lupancu TJ, Eivazitork M, Hamilton JA, Achuthan AA, Lee KM. CCL17\/TARC in autoimmunity and inflammation-not just a T-cell chemokine. Immunol Cell Biol. 2023;101:600\u20139. https:\/\/doi.org\/10.1111\/imcb.12644.","journal-title":"Immunol Cell Biol"},{"key":"1943_CR24","doi-asserted-by":"publisher","first-page":"339173","DOI":"10.1016\/j.aca.2021.339173","volume":"1187","author":"I Ten-Domenech","year":"2021","unstructured":"Ten-Domenech I, Moreno-Torres M, Castell JV, Quintas G, Kuligowski J. Extracting consistent biological information from functional results of metabolomic pathway analysis using the Mantel\u2019s test. Anal Chim Acta. 2021;1187:339173. https:\/\/doi.org\/10.1016\/j.aca.2021.339173.","journal-title":"Anal Chim Acta"},{"key":"1943_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaut.2019.01.012","volume":"99","author":"A Audemard-Verger","year":"2019","unstructured":"Audemard-Verger A, Pillebout E, Jamin A, Berthelot L, Aufray C, Martin B, Sannier A, Daugas E, Dechanet-Merville J, Richard Y, Monteiro R, Lucas B. Recruitment of CXCR3(+) T cells into injured tissues in adult IgA vasculitis patients correlates with disease activity. J Autoimmun. 2019;99:73\u201380. https:\/\/doi.org\/10.1016\/j.jaut.2019.01.012.","journal-title":"J Autoimmun"},{"key":"1943_CR26","doi-asserted-by":"publisher","first-page":"7517","DOI":"10.1038\/s41598-019-44032-6","volume":"9","author":"HA Kim","year":"2019","unstructured":"Kim HA, Kim YH, Jeon YK, Yang WI, Kwon JE, Han JH. Histopathology and expression of the chemokines CXCL10, CXCL13, and CXCR3 and the endogenous TLR-4 ligand S100A8\/A9 in lymph nodes of patients with adult-onset still\u2019s disease. Sci Rep. 2019;9:7517. https:\/\/doi.org\/10.1038\/s41598-019-44032-6.","journal-title":"Sci Rep"},{"key":"1943_CR27","doi-asserted-by":"publisher","unstructured":"Ferrari SM, Fallahi P, Ruffilli I, Elia G, Ragusa F, Paparo SR, Patrizio A, Mazzi V, Colaci M, Giuggioli D, Ferri C, Antonelli A. Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C? J Immunol Res 2019; 2019: 5878960. https:\/\/doi.org\/10.1155\/2019\/5878960","DOI":"10.1155\/2019\/5878960"},{"key":"1943_CR28","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.5001\/omj.2020.21","volume":"35","author":"A Nazari","year":"2020","unstructured":"Nazari A, Ahmadi Z, Hassanshahi G, Abbasifard M, Taghipour Z, Falahati-Pour SK, Khorramdelazad H. Effective treatments for bladder Cancer affecting CXCL9\/CXCL10\/CXCL11\/CXCR3 Axis: a review. Oman Med J. 2020;35:e103. https:\/\/doi.org\/10.5001\/omj.2020.21.","journal-title":"Oman Med J"},{"key":"1943_CR29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.19723\/j.issn.1671-167X.2019.03.005","volume":"51","author":"J Zhang","year":"2019","unstructured":"Zhang J, Chen J, Guan GW, Zhang T, Lu FM, Chen XM. [Expression and clinical significance of chemokine CXCL10 and its receptor CXCR3 in hepatocellular carcinoma]. Beijing Da Xue Xue Bao Yi Xue Ban. 2019;51:402\u20138. https:\/\/doi.org\/10.19723\/j.issn.1671-167X.2019.03.005.","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"1943_CR30","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fimmu.2018.00428","volume":"9","author":"A Recke","year":"2018","unstructured":"Recke A, Regensburger AK, Weigold F, Muller A, Heidecke H, Marschner G, Hammers CM, Ludwig RJ, Riemekasten G. Autoantibodies in serum of systemic Scleroderma patients: peptide-based epitope mapping indicates increased binding to cytoplasmic domains of CXCR3. Front Immunol. 2018;9:428. https:\/\/doi.org\/10.3389\/fimmu.2018.00428.","journal-title":"Front Immunol"},{"key":"1943_CR31","doi-asserted-by":"publisher","first-page":"e12852","DOI":"10.1111\/sji.12852","volume":"91","author":"SLM Blokland","year":"2020","unstructured":"Blokland SLM, Kislat A, Homey B, Smithson GM, Kruize AA, Radstake T, van Roon JAG. Decreased circulating CXCR3\u2009+\u2009CCR9\u2009+\u2009T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjogren\u2019s syndrome to facilitate their concerted migration. Scand J Immunol. 2020;91:e12852. https:\/\/doi.org\/10.1111\/sji.12852.","journal-title":"Scand J Immunol"},{"key":"1943_CR32","doi-asserted-by":"publisher","unstructured":"Wood PL. Fatty acyl esters of Hydroxy fatty acid (FAHFA) lipid families. Metabolites. 2020;10. https:\/\/doi.org\/10.3390\/metabo10120512.","DOI":"10.3390\/metabo10120512"},{"key":"1943_CR33","doi-asserted-by":"publisher","first-page":"8798","DOI":"10.1021\/jacs.9b00045","volume":"141","author":"D Tan","year":"2019","unstructured":"Tan D, Ertunc ME, Konduri S, Zhang J, Pinto AM, Chu Q, Kahn BB, Siegel D, Saghatelian A. Discovery of FAHFA-Containing triacylglycerols and their metabolic regulation. J Am Chem Soc. 2019;141:8798\u2013806. https:\/\/doi.org\/10.1021\/jacs.9b00045.","journal-title":"J Am Chem Soc"},{"key":"1943_CR34","doi-asserted-by":"publisher","first-page":"100108","DOI":"10.1016\/j.jlr.2021.100108","volume":"62","author":"P Aryal","year":"2021","unstructured":"Aryal P, Syed I, Lee J, Patel R, Nelson AT, Siegel D, Saghatelian A, Kahn BB. Distinct biological activities of isomers from several families of branched fatty acid esters of hydroxy fatty acids (FAHFAs). J Lipid Res. 2021;62:100108. https:\/\/doi.org\/10.1016\/j.jlr.2021.100108.","journal-title":"J Lipid Res"},{"key":"1943_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/imr.12952","volume":"301","author":"T Laval","year":"2021","unstructured":"Laval T, Chaumont L, Demangel C. Not too fat to fight: the emerging role of macrophage fatty acid metabolism in immunity to Mycobacterium tuberculosis. Immunol Rev. 2021;301:84\u201397. https:\/\/doi.org\/10.1111\/imr.12952.","journal-title":"Immunol Rev"},{"key":"1943_CR36","doi-asserted-by":"publisher","unstructured":"Ren J, Lin J, Yu L, Yan M, Lysophosphatidylcholine. Potential target for the treatment of Chronic Pain. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms23158274.","DOI":"10.3390\/ijms23158274"},{"key":"1943_CR37","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3389\/fimmu.2018.00920","volume":"9","author":"HJ Lee","year":"2018","unstructured":"Lee HJ, Ko HJ, Song DK, Jung YJ. Lysophosphatidylcholine promotes Phagosome Maturation and regulates inflammatory Mediator Production through the Protein Kinase A-Phosphatidylinositol 3 Kinase-p38 mitogen-activated protein kinase signaling pathway during Mycobacterium tuberculosis infection in mouse macrophages. Front Immunol. 2018;9:920. https:\/\/doi.org\/10.3389\/fimmu.2018.00920.","journal-title":"Front Immunol"},{"key":"1943_CR38","doi-asserted-by":"publisher","first-page":"989","DOI":"10.14348\/molcells.2020.0030","volume":"43","author":"HJ Lee","year":"2020","unstructured":"Lee HJ, Hong WG, Woo Y, Ahn JH, Ko HJ, Kim H, Moon S, Hahn TW, Jung YM, Song DK, Jung YJ. Lysophosphatidylcholine enhances bactericidal activity by promoting Phagosome Maturation via the activation of the NF-kappaB pathway during Salmonella infection in mouse macrophages. Mol Cells. 2020;43:989\u20131001. https:\/\/doi.org\/10.14348\/molcells.2020.0030.","journal-title":"Mol Cells"},{"key":"1943_CR39","doi-asserted-by":"publisher","unstructured":"Niekamp P, Guzman G, Leier HC, Rashidfarrokhi A, Richina V, Pott F, Barisch C, Holthuis JCM, Tafesse FG. Sphingomyelin Biosynthesis Is Essential for Phagocytic Signaling during Mycobacterium tuberculosis Host Cell Entry. mBio 2021; 12. https:\/\/doi.org\/10.1128\/mBio.03141-20","DOI":"10.1128\/mBio.03141-20"},{"key":"1943_CR40","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3389\/fmicb.2018.00330","volume":"9","author":"C Chen","year":"2018","unstructured":"Chen C, Yan T, Liu L, Wang J, Jin Q. Identification of a novel serum biomarker for tuberculosis infection in Chinese HIV patients by iTRAQ-Based quantitative proteomics. Front Microbiol. 2018;9:330. https:\/\/doi.org\/10.3389\/fmicb.2018.00330.","journal-title":"Front Microbiol"},{"key":"1943_CR41","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/infdis\/jiad175","volume":"228","author":"S Chen","year":"2023","unstructured":"Chen S, Li C, Qin Z, Song L, Zhang S, Sun C, Zhuang P, Wang Y, Yang B, Ning L, Li Y. Serum metabolomic profiles for distinguishing Lung Cancer from Pulmonary Tuberculosis: identification of Rapid and Noninvasive Biomarker. J Infect Dis. 2023;228:1154\u201365. https:\/\/doi.org\/10.1093\/infdis\/jiad175.","journal-title":"J Infect Dis"},{"key":"1943_CR42","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.3389\/fimmu.2018.02427","volume":"9","author":"R Lubbers","year":"2018","unstructured":"Lubbers R, Sutherland JS, Goletti D, de Paus RA, van Moorsel CHM, Veltkamp M, Vestjens SMT, Bos WJW, Petrone L, Del Nonno F, Bajema IM, Dijkman K, Verreck FAW, Walzl G, Gelderman KA, Groeneveld GH, Geluk A, Ottenhoff THM, Joosten SA, Trouw LA. Complement component C1q as serum biomarker to detect active tuberculosis. Front Immunol. 2018;9:2427. https:\/\/doi.org\/10.3389\/fimmu.2018.02427.","journal-title":"Front Immunol"},{"key":"1943_CR43","doi-asserted-by":"publisher","unstructured":"Goossens SN, Sampson SL, Van Rie A. Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis. Clin Microbiol Rev. 2020;34. https:\/\/doi.org\/10.1128\/CMR.00141-20.","DOI":"10.1128\/CMR.00141-20"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-024-01943-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-024-01943-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-024-01943-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T16:19:38Z","timestamp":1730909978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-024-01943-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1943"],"URL":"https:\/\/doi.org\/10.1007\/s00011-024-01943-z","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"22 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Tongji University affiliated Shanghai Pulmonary Hospital (No. K21-257), with the informed written consent of each participant. The study was conducted in accordance with the principles of the Declaration of Helsinki and the ethical and biosafety agreements of the institution.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}